MedTrace Logo

Effect of Loading of Midazolam or Dexmedetomidine on Hemodynamics

NCT02634021 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-04-20

No results posted yet for this study

Summary

Loading dose of dexmedetomidine is related hemodynamic instability such as bradycardia and hypertension.

Conditions

  • Knee Injuries

Interventions

DRUG

dexmedetomidine group

intravenous loading of dexmedetomidine for 1 mcg/kg

DRUG

midazolam group

intravenous loading of midazolam for 0.1 mg/kg

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Principal Investigators

  • Seong-Hyop Kim, Professor · Konkuk University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02634021 on ClinicalTrials.gov